70 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMRN Amarin Corporation plc $2.83 $838.67M N/A
Article Searches
Amarin Corporation plc (AMRN) CEO John Thero Presents at Goldman Sachs 40th Annual Global Healthcare Conference (Transcript) https://seekingalpha.com/article/4269987-amarin-corporation-plc-amrn-ceo-john-thero-presents-goldman-sachs-40th-annual-global?source=feed_sector_healthcare Jun 12, 2019 - Amarin Corporation plc (NASDAQ:AMRN) Goldman Sachs 40th Annual Global Healthcare Conference Call June 12, 2019 4:20 P.M. ET Company Participants John Thero - President and Chief Executive Officer Conf
Amarin Corporation plc (AMRN) CEO John Thero Presents at Jefferies 2019 Healthcare Conference (Transcript) https://seekingalpha.com/article/4268825-amarin-corporation-plc-amrn-ceo-john-thero-presents-jefferies-2019-healthcare-conference?source=feed_sector_healthcare Jun 06, 2019 - Amarin Corporation plc (NASDAQ:AMRN) Jefferies 2019 Healthcare Conference Jun 06, 2019, 9:30 am ET Executives John Thero - President, Chief Executive Officer Analysts Michael Yee - Jefferies Presentat
Amarin Rises on Priority Review for Vascepa Label Expansion http://www.zacks.com/stock/news/422062/amarin-rises-on-priority-review-for-vascepa-label-expansion?cid=CS-ZC-FT-422062 May 30, 2019 - Amarin's (AMRN) label expansion application for hypertriglyceridemia drug, Vascepa, gets priority review from the FDA.
3 Top Mid-Cap Stocks to Buy Right Now https://www.fool.com/investing/2019/05/30/3-top-mid-cap-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 May 30, 2019 - If you are looking for interesting investment opportunities, then this diverse trio should be on your watch list.
AMRN, CARA, ANF and GOOS among midday movers https://seekingalpha.com/news/3467584-amrn-cara-anf-goos-among-midday-movers?source=feed_news_all May 29, 2019 - Gainers: Eltek (NASDAQ:ELTK) +373%. Valeritas Holdings (NASDAQ:VLRX) +40%. Soliton (NASDAQ:SOLY) +34%. Technical Communications Corporation (NASDAQ:TCCO) +30%. ReWalk Robotics (NASDAQ:RWLK) +28%. Nets
Amarin's (AMRN) CEO John Thero on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4258570-amarins-amrn-ceo-john-thero-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 01, 2019 - Amarin Corporation PLC (NASDAQ:AMRN) Q1 2019 Earnings Conference Call May 1, 2019 7:30 AM ET Company Participants Elisabeth Schwartz – Senior Director-Investor Relations John Thero – President and Chi
Amarin Corporation plc (AMRN) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/01/amarin-corporation-plc-amrn-q1-2019-earnings-call.aspx?source=iedfolrf0000001 May 01, 2019 - AMRN earnings call for the period ending March 31, 2019.
Amarin (AMRN) Beats Estimates for Earnings & Revenues in Q1 http://www.zacks.com/stock/news/406430/amarin-amrn-beats-estimates-for-earnings-revenues-in-q1?cid=CS-ZC-FT-406430 May 01, 2019 - Amarin (AMRN) surpasses estimates for earnings and sales in the first quarter of 2019.
What's in the Cards for Amarin (AMRN) This Earnings Season? http://www.zacks.com/stock/news/398903/whats-in-the-cards-for-amarin-amrn-this-earnings-season?cid=CS-ZC-FT-398903 Apr 24, 2019 - Amarin's (AMRN) cardiovascular drug, Vascepa to drive sales in the first quarter.
Implied Volatility Surging for Amarin (AMRN) Stock Options http://www.zacks.com/stock/news/363974/implied-volatility-surging-for-amarin-amrn-stock-options?cid=CS-ZC-FT-363974 Mar 25, 2019 - Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

Pages: 1234567

Page 1>